Eirion Therapeutics to Present at the 2024 IMCAS WORLD CONGRESS
/PRNewswire/ -- Eirion Therapeutics Inc., a biopharmaceutical company focused on developing innovative aesthetic prescription product offerings, today...
Source: prnewswire.com
Jon Edelson News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jon Edelson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jon Edelson Today - Breaking & Trending Today
Eirion Therapeutics to Participate in the 2023 IMCAS WORLD CONGRESS
/PRNewswire/ -- Eirion Therapeutics Inc., a biopharmaceutical company focused on developing innovative aesthetic prescription product offerings, today...
Source: prnewswire.com
Eirion Therapeutics Announces Initiation of First-in-Human Clinical Trial Evaluating Next Generation, Ready-to-Use Liquid Injectable Neuromodulator AI-09 for the Treatment of Wrinkles
/PRNewswire/ -- Eirion Therapeutics Inc. announced today that the first participants have been dosed in a Phase 1/2 clinical trial for the treatment of...
Source: prnewswire.com
Eirion Therapeutics, Inc. Closes $40 Million Series A Investment and Licensing Deal with Shanghai Haohai Biological Technology Ltd.
Share this article Share this article WOBURN, Mass., March 9, 2021 /PRNewswire/ -- Today, Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced a deal with Shanghai Haohai Biological Technology Ltd. ("Haohai") that will result in a $32 million Series A Preferred Stock investment into Eirion along with exclusive licenses that will be for all of Eirion's products for the territory of China in exchange for an upfront payment in the amount of $8 million. The deal is structured in segments over the next approximately 18 months. Haohai is a l...
Source: prnewswire.com